Evaluation of Various Static and Dynamic Modeling Methods to Predict Clinical CYP3A Induction Using In Vitro CYP3A4 mRNA Induction DataHeidi J. Einolf, Ping Zhao, Mohamad Shebley et al.|Clinical Pharmacology & Therapeutics|2013Cited by 93
Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive ControlNiresh Hariparsad, Donald Tweedie, Diane Ramsden et al.|Drug Metabolism and Disposition|2017Cited by 46
Evaluation of CYP2B6 Induction and Prediction of Clinical Drug–Drug Interactions: Considerations from the IQ Consortium Induction Working Group—An Industry PerspectiveOdette A. Fahmi, Mohamad Shebley, Jairam Palamanda et al.|Drug Metabolism and Disposition|2016Cited by 45